M ycoplasma pneumoniae carriage evades induction of protective mucosal antibodies

Ruben Cornelis Anthonie de Groot1, Silvia Cristina Estevão1, Patrick Michael Meyer Sauteur2

  • 1Dept of Pediatrics, Laboratory of Pediatrics, Erasmus MC University Medical Centre Rotterdam - Sophia Children's Hospital, Rotterdam, The Netherlands.

Abstract

Insights

Mucosal antibodies against Mycoplasma pneumoniae are induced during infection, not carriage. These antibodies prevent bacterial adhesion, offering insights for vaccine development against childhood pneumonia.

Area of Science:

  • Immunology
  • Microbiology
  • Pediatrics

Background:

  • Mycoplasma pneumoniae is a leading cause of pediatric community-acquired pneumonia (CAP).
  • Emerging macrolide resistance in M. pneumoniae necessitates alternative prevention strategies like vaccines.
  • Limited understanding of immune responses to M. pneumoniae hinders vaccine design.

Purpose of the Study:

  • To investigate antibody responses during Mycoplasma pneumoniae respiratory tract infection and asymptomatic carriage.
  • To determine if M. pneumoniae carriage induces mucosal or systemic antibody responses.
  • To assess the functional role of M. pneumoniae-specific antibodies in preventing bacterial adhesion.

Main Methods:

  • Studied antibody responses in two distinct pediatric cohorts.
  • Employed a nested case-control study design (n=80) comparing carriers and controls.
  • Utilized in vitro adhesion assays to evaluate antibody function.

Main Results:

  • Asymptomatic M. pneumoniae carriage did not elevate mucosal or systemic antibodies.
  • M. pneumoniae infection significantly increased mucosal IgA and IgG levels.
  • High levels of M. pneumoniae-specific antibodies in secretions inhibited bacterial adhesion to respiratory cells.

Conclusions:

  • M. pneumoniae-specific mucosal antibodies protect against bacterial adhesion to respiratory epithelial cells.
  • These protective antibodies are induced solely during active infection, not asymptomatic carriage.
  • Findings contrast with other bacteria like Streptococcus pneumoniae, where carriage induces mucosal antibodies.